This paper reports the functional characterization of AtrBp, an ABC transporter from Aspergillus nidulans. AtrBp is a multidrug transporter and has affinity to substrates belonging to all major classes of agricultural fungicides and some natural toxic compounds. The substrate profile of AtrBp was determined by assessing the sensitivity of deletion and overexpression mutants of atrB to several toxicants. All mutants showed normal growth as compared to control isolates. ∆atrB mutants displayed increased sensitivity to anilinopyrimidine, benzimidazole, phenylpyrrole, phenylpyridylamine, strobirulin and some azole fungicides. Increased sensitivity to the natural toxic compounds camptothecin (alkaloid), the phytoalexin resveratrol (stilbene) and the mutagen 4-nitroquinoline oxide was also found. Overexpression mutants were less sensitive to a wide range of chemicals. In addition to the compounds mentioned above, decreased sensitivity to a broader range of azoles, dicarboximides, quintozene, acriflavine and rhodamine 6G was observed. Decreased sensitivity in overexpression mutants negatively correlated with levels of atrB expression. Interestingly, the overexpression mutants displayed increased sensitivity to dithiocarbamate fungicides, chlorothalonil and the iron-activated antibiotic phleomycin. Accumulation of the azole fungicide [ 14 C]fenarimol by the overexpression mutants was lower as compared to the parental isolate, demonstrating that AtrBp acts by preventing intracellular accumulation of the toxicant. Various metabolic inhibitors increased accumulation levels of [ 14 C]fenarimol in the overexpression mutants to wildtype levels, indicating that reduced accumulation of the fungicide in these mutants is due to increased energy-dependent efflux as a result of higher pump capacity of AtrBp.
INTRODUCTION
The use of fungicides in crop production continues to be essential for effective control of plant diseases and assurance of high crop yields. Recently, new classes of fungicides have been developed in order to meet the public demand for environmentally safer products. These modern fungicides include the classes of anilinopyrimidines, phenoxyquinolines, phenylpyrroles and strobilurins (Knight et al., 1997) , which are highly selective site-specific inhibitors of the metabolism of target organisms. A disadvantage of fungicides with a specific mode of action is the high risk of resistance development (Jespers & De Waard, 1993) . This has been the case for the first generation of modern fungicides (e.g. benzimidazoles, phenylamides, dicarboximides, and sterol biosynthesis inhibitors), whose activity was significantly reduced by the development of resistance in target populations. In some cases, resistance developed not only to a specific fungicide but also to structurally and functionally unrelated compounds. This phenomenon, known as multidrug resistance (MDR), has been reported to operate in a broad range of organisms and is of major concern in clinical medicine. Therefore, understanding the mechanisms of the development of MDR is important for society in general.
A common mechanism of MDR is the overexpression of energy-dependent multidrug efflux pumps, also known as multidrug transporter proteins or P-glycoproteins (P-gp). Overexpression of such proteins in cancer cells results in MDR to chemotherapeutic drugs and other hydrophobic pharmacological agents (Ambudkar et al., 1999) . P-glycoproteins belong to the ubiquitous superfamily of ATP-binding cassette (ABC) transporters. Besides multidrug transporters, the family includes proteins involved in transmembrane transport of various substances such as ions, amino acids, peptides, sugars, vitamins, steroid hormones, bile acids and phospholipids (Higgins, 1992 (Higgins, , 1994 van Helvoort et al., 1996) .
In filamentous fungi, MDR was first reported for laboratory-generated mutants of Aspergillus nidulans selected for resistance to azole fungicides, also described as sterol biosynthesis inhibitors (van Tuyl, 1977) . Resistance to azoles in isogenic mutants is based on an energy-dependent efflux mechanism which results in decreased accumulation of compounds in fungal mycelium, similarly to the phenomenon observed in cancer cells (De Waard & Van Nistelrooy, 1979 , 1980 . This mechanism also operates in plant pathogens such as Penicillium italicum, Botrytis cinerea, Nectria haematococca, and probably Mycosphaerella graminicola (De Waard et al., 1995 ; Joseph-Horne et al., 1996) . To date, at least five ABC transporters highly homologous to multidrug-efflux pumps from other organisms have been described for A. nidulans (Andrade et al., 1999 ; Angermayr et al., 1999 ; Del Sorbo et al., 1997) . This paper describes the functional characterization of atrB, a previously described gene of A. nidulans . AtrBp displays a high degree of sequence homology to BcatrBp from B. cinerea, Mgatr5p from M. graminicola, Pmr1p from Penicillium digitatum, and Abc1p from Magnaporthe grisea (Goodall et al., 1999 ; Nakaune et al., 1998 ; Schoonbeek et al., 1998 ; Urban et al., 1999) . A high degree of homology also exists with ABC proteins classified in subcluster I.1 from Saccharomyces cerevisiae (Decottignies & Goffeau, 1997) , Bfr1p from Schizosaccharomyces pombe (Nagao et al., 1995) , and the Cdr1p and Cdr2p proteins from Candida albicans (Prasad et al., 1995 ; Sanglard et al., 1996 Sanglard et al., , 1997 . Most of these proteins have been characterized as multidrug-efflux pumps. Previously, we reported that heterologous overexpression of atrB in S. cerevisiae restores wild-type sensitivity to cycloheximide, tentatively indicating that AtrBp is also a multidrug-efflux protein. Here, we describe in detail the substrate specificity of the multidrug transporter AtrBp by phenotype characterization of knock-out and overexpression mutants of A. nidulans with respect to fungicide sensitivity. ∆atrB strains display increased sensitivity to several classes of fungicides and some natural toxic compounds. atrB overexpression mutants are less sensitive to a wide range of compounds. Interestingly, these overexpression mutants display at the same time increased sensitivity to some conventional fungicides and phleomycin, an iron-activated antibiotic. These results clearly indicate that AtrBp is a multidrug transporter involved in protection against natural toxins and xenobiotics and might play a role in iron metabolism.
METHODS
Strains, plasmids and media. The A. nidulans strains and plasmids used in this study are listed in Table 1 . All strains were derived from Glasgow stocks. Standard techniques for manipulation and growth were as described by Pontecorvo et al. (1953) . Escherichia coli DH5α was used as a host in plasmid propagation.
Nucleic acid manipulations and molecular biological techniques. Freshly harvested conidia obtained from confluent plate cultures of A. nidulans, grown for 4-5 d at 37 mC, were used as inoculum source for liquid cultures at a density of 10( conidia ml − ". Germlings harvested after 14 h incubation at 37 mC were used for nucleic acid isolation according to Raeder & Broda (1985) and Logemann et al. (1987) . The Random Primers DNA Labelling System (Gibco-BRL) was used to generate radioactively labelled oligonucleotide probes with [α-$#P]dATP. Southern, Northern and dot blot hybridizations were performed using Hybond N + (DNA) and Hybond N (RNA) nylon membranes (Amersham), according to the manufacturer's instructions. Overnight hybridized blots were washed at 65 mC with 0n1 % SSCj0n1 % SDS solution. The pGEM-3Zf(j) and pGEM-T (Promega) vectors were used for cloning DNA fragments and PCR products, respectively. Sequencing was carried out by the dideoxy chain-termination method (Sanger et al., 1977) . PCR reactions were performed using a Perkin-Elmer DNA thermal cycler 480 and Expand High Fidelity PCR kit (Boehringer Mannheim). Sequences were analysed using the DNAstar package (DNASTAR).
Disruption constructs. Primers for amplification of the atrB locus were designed in the 5h and 3h UTR (untranslated regions). Artificial EcoRI sites were included in the primers to allow further subcloning of the PCR product. Primer sequences were 5h-CGTGAATTCCTGGATGGTTCAGCT-TA-3h and 5h-TAAGAATTCTTCAAGTTCGTCGAAGA-CG-3h. A 5n2 kb amplified PCR product using the lambda clone an2 as template DNA was cloned in pGEM-T and coded pTB. This clone was checked by restriction analysis and sequencing. Furthermore, the 8n0 kb pTB clone was restricted with BamHI and a 5n15 kb DNA fragment was used to clone the pyrG from Aspergillus oryzae as a 3n8 kb BamHI insert from pAO4-2 restricted with BamHI (de Ruiter-Jacobs et al., 1989) . This construct was coded pAOB. The final transformation construct, a 5n95 kb EcoRI DNA fragment (DB), was obtained by restriction of pAOB Clutterbuck (1993) . † See Methods for detailed information on cloning procedures.
with EcoRI. For generation of the control strains, the pAO4-2 clone was used for transformation (de Ruiter-Jacobs et al., 1989) .
Overexpression constructs. The overexpression construct was made by restriction of pTB with EcoRI and a 5n2 kb DNA fragment containing the whole atrB locus was cloned in the EcoRI site of pPL6 (Oakley et al., 1987) . The resulting 9n4 kb vector, coded pOB, was used for transformation. The control strains (PPL6) were obtained by transformation with the pPL6 vector.
Preparation of protoplasts and transformation. Mycelial protoplasts were prepared as described by Wernars et al. (1985) with minor modifications. Liquid minimal medium (MM) supplemented with 2 g Casamino acids l − ", 0n5 g yeast extract l − " and auxotrophic markers was inoculated with 10' conidia ml − " and incubated overnight at 37 mC and 300 r.p.m. in an orbital incubator for 16 h. The germlings were harvested through Mira-Cloth, washed twice with sterile water and twice with STC buffer (1n0 M sorbitol, 10 mM Tris\HCl pH 7n5, 50 mM CaCl # ) and squeezed between paper towels to remove excess of liquid. Protoplasts were released by incubation of 1 g mycelium at 30 mC and 100 r.p.m., resuspended in 20 ml of filter-sterilized iso-osmotic S0.8MC medium containing lytic enzymes (5 mg Novozym 234 ml − ", 0n8 M KCl, 50 mM CaCl # , 20 mM MES pH 5n8) for about 2 h. The protoplast suspension was filtered over glass wool, diluted (1 : 1, v\v) with STC buffer and incubated on ice for 10 min. Then, protoplasts were collected by centrifugation (10 min, 0 mC, 3000 r.p.m.) and washed twice with STC buffer. Transformation was performed as described by van Heemst et al. (1997) using purified DNA of transformation constructs DB (3n5 µg) and pOB (5n0 µg) dissolved in sterile water (15 µl). Lilly, fenpiclonil, fludioxonil and trifloxystrobin by Novartis, kresoxim-methyl by BASF, fenarimol by Dow Elanco and imazalil nitrate and ketoconazole by Janssen Pharmaceuticals. All other chemicals tested were purchased from Sigma. For statistical analysis a radial growth test was performed in four replicates, at one concentration around the determined EC &! value of the compounds for the control strains. These concentrations were : azoxystrobin (0n05 µg ml − "), carbendazim (0n3 µg ml − "), cycloheximide (50 µg ml − "), cyprodinil (0n03 µg ml − "), eugenol (100 µg ml − "), fenarimol (3 µg ml − "), fenpiclonil (0n3 µg ml − "), fluazinam (0n3 µg ml − "), fludioxonil (0n1 µg ml − "), imazalil nitrate (0n05 µg ml − "), iprodione (5 µg ml − "), itraconazole (0n05 µg ml − "), kresoxim-methyl (0n05 µg ml − "), miconazole (0n5 µg ml − "), nigericin (3 µg ml − "), sodium o-phenylphenate (15 µg ml − "), nystatin (10 µg ml − "), 4-nitroquinoline oxide (1 µg ml − "), phleomycin (30 µg ml − "), prochloraz (0n1 µg ml − "), propiconazole (1 µg ml − "), pyrimethanil (0n3 µg ml − "), quintozene (10 µg ml − "), resveratrol (300 µg ml − "), rhodamine 6G (5 µg ml − "), thiabendazole (3 µg ml − "), trifloxystrobin (0n01 µg ml − "). The compounds were added from concentrated solutions in methanol. Amphotericin B (30 µg ml − "), camptothecin (10 µg ml − "), cilofungin (0n03 µg ml − "), chlorothalonil (3n0 µg ml − "), ferbam (30 µg ml − ") and thiram (30 µg ml − "), were added from concentrated solutions in DMSO. Acriflavine (3 µg ml -") was dissolved in sterile water. The final concentration of the solvents in the agar was the same for all treatments and never exceeded 1 %. Analysis of variance from two independent experiments was applied as described by Snedecor & Cochran (1989) . Significant differences were obtained by comparing the mean values of colony size of control strains and mutants using Tukey's test (P 0n05). 
RESULTS

Generation of ∆atrB mutants
To characterize the substrate specificity of AtrBp and its role in MDR, we have generated deletion mutants by replacing the major part of the coding region of atrB with the orotidine-5h-phosphate decarboxylase (pyrG) encoding gene of A. oryzae. The uridine-auxotrophic strain WG488 of A. nidulans was used as the recipient strain for transformation and selection of transformants was based on uridine prototrophy. The use of the heterologous selectable marker of A. oryzae minimizes the chance of integration of the construct at the pyrG locus of A. nidulans. The schematic representation of the disruption strategy used is given in Fig. 1(a) . Southern blot analysis confirmed replacement of the wild-type allele of atrB in all mutants tested (Fig. 1b) . The replacement of the atrB locus was confirmed by the expected shift in size of the restriction fragments when the blots were hybridized with probe B1 (left panel). When the same blots were hybridized with probe B2, a smaller hybridizing fragment as compared to the wildtype locus (lane 1, right panel) was expected to occur (lanes 2-9). However, in some of the mutants (lanes 2, 3 and 6) a restriction fragment of the same size as the wildtype locus (lane 1) was still present and indicated that these mutants are heterokaryons. For further analysis two independent mutants DB5 ( Fig. 1b ; lane 4) and DB21 ( Fig. 1b ; lane 9) were selected. Northern blot analysis was carried out with total RNA isolated from germlings treated with cycloheximide, a strong inducer of atrB transcript levels. This treatment did not reveal any signal of mRNA from atrB in the ∆atrB mutants, whereas transcript levels of atrD were the same in all strains tested (Fig. 1c) . These observations confirm that atrB was functionally deleted.
Generation of overexpression mutants of atrB
Generation of mutants with increased copy number of atrB was achieved by transformation of strain WG488 with construct pOB, which contains a genomic copy of atrB comprising the coding region plus the 5h and 3h UTR. This construct was cloned in the pPL6 vector (Oakley et al., 1987) , which contains the pyrG gene from A. nidulans. A schematic representation of the transformation construct coded by pOB is presented in Fig.  2(a) . After selection of transformants based on uridine prototrophy, sensitivity to camptothecin was tested. This compound was selected because ∆atrB mutants displayed a strong increase in sensitivity to this compound as compared to control isolates (Fig. 2c, left  panel) . Therefore, increase in the copy number of atrB should lead to decreased sensitivity to camptothecin. Using this screening procedure, we isolated mutants with different levels of resistance to camptothecin, as compared to the control isolates (data not shown). We postulated that this differential degree of resistance could be due to different copy number of atrB. To investigate this assumption, mutants displaying different levels (low, intermediate and high) of resistance to camptothecin were selected for further characterization (OB7, OB16 and OB35, respectively). Southern blot analysis confirmed an increase in atrB copy number in all strains tested (data not shown) and Northern blot analysis confirmed that sensitivity to camptothecin in the different overexpression mutants was negatively correlated with levels of atrB transcription ( Fig. 2b and right panel of Fig. 2c) . 
Phenotype characterization
Two independent monospore strains of ∆atrB, DB5 and DB21 were selected for phenotype characterization with respect to sensitivity to fungicides and other toxicants. Strains PAO-1 and PAO-2, transformed with a construct containing the pyrG from A. oryzae only, were used as controls. The deletion mutants grew normally and no differences in radial growth rates were observed. A radial growth toxicity test was used to evaluate the role of AtrBp in drug sensitivity. The activity of 50 compounds (see Methods) was tested. ∆atrB mutants displayed increased sensitivity to the fungicides azoxystrobin, camptothecin, carbendazim, cyprodinil, fenpiclonil, fludioxonil, fluazinam, ketoconazole, kresoxim-methyl, 4-nitroquinoline oxide, prochloraz, propiconazole, resveratrol, thiabendazole, trifloxystrobin, when compared to the control isolates tested (Fig. 3a , Tables 2 and 3 ). ∆atrB mutants did not display increased sensitivity to cycloheximide, although we have shown previously that atrB was able to confer decreased sensitivity to this compound when overexpressed in yeast cells .
Sensitivity of the overexpression mutants OB7, OB16 and OB35 to the same set of compounds described above was also determined. Strain PPL6-1 transformed with the pPL6 construct was used as control strain. The overexpression mutants displayed decreased sensitivity to a wide range of compounds (Tables 2 and 3) . Furthermore, the degree of decreased sensitivity to these compounds was positively correlated with the level of atrB expression (Fig. 3b, Tables 2 and 3 ). Most interestingly, we also observed that the overexpression mutants displayed increased sensitivity to compounds such as chlorothalonil, ferbam, thiram and phleomycin. The increased sensitivity was negatively correlated with the level of atrB expression (Fig. 3c , Tables 2 and 3) .
AtrB causes energy-dependent efflux of [
C]fenarimol
In genetically defined MDR mutants of A. nidulans, resistance to the azole fungicide fenarimol is based on increased energy-dependent efflux activity which results in decreased cytoplasmic drug accumulation (De Waard & Van Nistelrooy, 1979 , 1980 . We could not find any significant difference in ["%C]fenarimol accumulation between the control PAO and the ∆atrB strains (Fig. 4a) . However, initial ["%C]fenarimol accumulation in atrB overexpression mutants was lower than in the control strain PPL6-1 (Fig. 4b) . In radial growth tests, mutants overexpressing atrB had decreased sensitivity to fenarimol.
We also confirmed that the efflux mechanism operating in the overexpression mutant OB35, as in the control strain PPL6-1, was energy-dependent. This conclusion is based on results of experiments in which the effect of respiratory inhibitors (oligomycin and CCCP) and an inhibitor of membrane ATPases (orthovanadate) on accumulation of ["%C]fenarimol was tested. Addition of these compounds instantly increased accumulation of ["%C]fenarimol (Fig. 4c ). This effect is ascribed to inhibition of energy-dependent ["%C]fenarimol efflux activity as reported previously (De Waard & Van Nistelrooy, 1980) . In the same way, we have checked the potency of two substrates (kresoxim-methyl and iprodione) of AtrBp, to competitively inhibit the efflux of ["%C]fenarimol. These compounds also stimulate the accumulation of ["%C]fenarimol. The inhibitory activity of iprodione seems to be transient (Fig. 4d) . 
DISCUSSION
We have shown that deletion and overexpression mutants of atrB in A. nidulans display differential sensitivity to structurally unrelated compounds. These results indicate that the ABC transporter AtrBp is a multidrug transporter and accepts these compounds as substrates. We propose that the reduced intracellular accumulation of ["%C]fenarimol in overexpression mutants of atrB and the decreased sensitivity to fenarimol can be explained by increased efflux activity of the fungicide.
Deletion strains of atrB displayed increased sensitivity to different classes of agricultural fungicides : cyprodinil (anilinopyrimidine), ketoconazole, prochloraz and propiconazole (azoles), carbendazim (benzimidazole), fenpiclonil and fludioxonil (phenylpyrroles), fluazinam (phenylpyridianine) and azoxystrobin, kresoxim-methyl and trifloxystrobin (strobirulins). Increased sensitivity was also observed for other compounds such as 4-nitroquinoline oxide (mutagen), camptothecin (plant alkaloid) and the phytoalexin resveratrol (stilbene). These results indicate that these compounds are substrates of AtrBp.
Analogous to ABC transporters of yeast (Kolaczkowski et al., 1998 ; Sanglard et al., 1996 Sanglard et al., , 1997 , ABC transporters of A. nidulans may have distinct but overlapping substrate specificities. This makes it difficult to assess the substrate profile of an ABC protein using single knock-out mutants. To overcome this problem, the sensitivity of overexpression mutants to toxicants was also determined. This approach led to the characterization of additional substrates, such as fenarimol, imazalil and miconazole (azoles), pyrimethanil (anilinopyrimidine), iprodione and vinchlozolin (dicarboximides), quintozene (aromatic fungicides), acriflavine and rhodamine 6G. In all cases, an inverse correlation between levels of atrB expression in the overexpression mutants and sensitivity to toxicants was established. These results provide evidence that AtrBp pump activity is responsible for the decreased sensitivity to toxicants. The results also imply that the use of overexpression mutants avoids or minimizes the problem of redundancy of ABC transporters in characterization of the substrate specificity of AtrBp. Phenotype characterization of multiple deletion mutants is another approach that can be used to minimize the problem of redundancy. This approach was used to characterize the drug-resistance profile of the major ABC transporters of the PDR network from Saccharomyces cerevisae (Kolaczkowski et al., 1998 toxic compounds. Several fungicides, similar to the ones used in our study, appeared to be ABC-transporter substrates in that organism.
The transient accumulation of ["%C]fenarimol in the ∆atrB mutants and control strains is similar. In constrast, the overexpression mutants have a lower initial level of ["%C]fenarimol accumulation. These results indicate that AtrBp can act as a fenarimol efflux pump. However, results also suggest that A. nidulans has (an) additional efflux pump(s) accepting fenarimol as substrate. In ∆atrB mutants, such additional efflux pumps may compensate for the absence of AtrBp, resulting in similar patterns of ["%C]fenarimol accumulation. Such compensating efflux pumps are still unknown but it might be one of the many ABC-transporter-candidate genes present in the expressed sequence tag (EST) database of A. nidulans (Roe et al., 1998) .
Restoration of wild-type levels of ["%C]fenarimol accumulation in the overexpression mutant OB35 after addition of the respiratory inhibitors (CCCP and oligomycin) and an inhibitor of membrane ATPases (orthovanadate), demonstrates that the ["%C]fenarimol efflux is energy-dependent. This may be due to a direct effect of the inhibitor on the AtrB protein (vanadate), an effect on ATP synthesis in mitochondria (CCCP, oligomycin), and indirectly via dissipation of the proton-motive force (CCCP). Furthermore, identified substrates in the toxicity assays, such as kresoxim-methyl and iprodione, also stimulate accumulation of ["%C]fenarimol, suggesting that these compounds are competitive inhibitors of ["%C]fenarimol efflux. Interestingly, a different pattern of inhibition for the two compounds was observed. First, the iprodione concentration (300 µM) required to increase ["%C]fenarimol accumulation was ten times higher than the one used for fenarimol (30 µM). Kresoxim-methyl showed this effect at equimolar concentrations (30 µM). This suggests that AtrBp has a higher affinity for kresoxim-methyl than for iprodione. Altered sensitivity to iprodione was only detected in the
